Investors

Board of Directors

Chris Rigg, CEO

Chris brings with him a track record of delivering results in environments of change having previously been Managing Director of eaga plc's solar business, where he led a £300m fundraise to support its development, and Chief Executive Officer of Northern Recruitment Group Limited.

Chris has also had a number of senior financial positions including Corporate Finance Director at Deloitte, Group Corporate Finance Director at eaga plc and head of large corporate lending at Barclays Bank in the North East of England.

Gerard Murray, CFO

A chartered accountant who qualified with Arthur Andersen, Gerard was appointed Chief Financial Officer in January 2017. He joined the Group from Ardent Hire Solutions Limited, a private equity backed plant hire business.

Gerard brings with him significant experience of listed companies having been Chief Financial Officer of Reg Vardy plc for ten years and Northgate plc for five years. Both of these companies experienced considerable growth and change during the periods that Gerard served on their respective boards. More recently Gerard gained sector experience as Group Finance Director of Immunodiagnostic System Holdings PLC in 2012 before joining Benfield Motor Group, a family-owned motor retailer, which was sold to Lookers plc in 2015.

Non-executives

Ian Johnson, Non-Executive Chairman

A chartered biologist and a member of the Royal Society of Biology and the Institute of Directors, Ian was appointed Non-executive Chairman in October 2016.

Ian is an experienced Director in the healthcare and life science sector. He was founder and Chief Executive Officer of Biotrace International plc until its sale to 3M in 2006 and is currently Executive Chairman of Bioquell PLC.

Ian has also served on the boards of various public and private companies in strategic consultancy and business development capacities including Cyprotex plc, Celsis International, Evans Analytical Group, MyCelx Technologies Corporation and AOI Medical Inc.

Dr John Brown, Senior Independent Non-Executive Director

Dr John Brown was appointed Non-executive Director in October 2016.

An experienced Non-executive Director who has extensive experience in the life sciences and healthcare sectors, John is Chairman of Synpromics Ltd and the Cell and Gene Therapy Catapult and a Director of Electrical Geodesics Inc.

His board experience includes his roles as Chairman of Kyowa Kirin International, Touch Bionics Ltd, BTG plc, and AxisShield plc, and as a Director of Vectura Group plc.

Christopher Mills, Non-Executive Director

Christopher is an experienced Non-executive Director and was appointed to the Board in October 2016.

Christopher founded Harwood Capital Management Ltd in 2011, a successor to its former parent company J O Hambro Capital Management Ltd, which he co-founded in 1993.

He is Chief Executive of North Atlantic Smaller Companies Investment Trust plc, a Director and Investment Manager of Oryx International Growth Fund Ltd and Chief Investment Officer of Harwood Capital LLP. He is also a Non-executive Director of several AIM-listed companies.

Christopher was a Director of Invesco MIM, where he was head of North American investments and venture capital and of Samuel Montagu International.

 

Page last updated: 2 May 2017

 
Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
Biodose Intelligent Medication Management